Insider Transactions in Q4 2024 at Amylyx Pharmaceuticals, Inc. (AMLX)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2024
|
Camille L Bedrosian Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,421
-3.77%
|
$27,105
$5.54 P/Share
|
|
Nov 04
2024
|
Justin B. Klee Co-Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
63,690
+1.96%
|
$63,690
$1.57 P/Share
|